Gudrun Boysen

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION

Palle Petersen, J Godtfredsen, Gudrun Boysen et al. · The Lancet · 1989 · 1.8K citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +11

Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

Ian Graham, Dan Atar, Knut Borch‐Johnsen et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 2007 · 1.7K citations

Hypertension, Adult Cardiac Surgery, Preventive Cardiology +27

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial

Else Charlotte Sandset, Philip M. Bath, Gudrun Boysen et al. · The Lancet · 2011 · 531 citations

Thrombosis, Hypertension, Cardiovascular Disease +13

Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study

Gudrun Boysen, J Nyboe · BMJ · 1994 · 368 citations · Full text